| Heart disease and stroke statistics—2013 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, WB Borden, ... circulation 127 (1), e6-e245, 2013 | 83979* | 2013 |
| Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing … RM Lang, M Bierig, RB Devereux, FA Flachskampf, E Foster, PA Pellikka, ... Journal of the American society of echocardiography 18 (12), 1440-1463, 2005 | 12334 | 2005 |
| 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on … RA Nishimura, CM Otto, RO Bonow, BA Carabello, JP Erwin, RA Guyton, ... Journal of the American College of Cardiology 63 (22), e57-e185, 2014 | 9772* | 2014 |
| Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography: endorsed by the European Association of … LG Rudski, WW Lai, J Afilalo, L Hua, MD Handschumacher, ... Journal of the American society of echocardiography 23 (7), 685-713, 2010 | 8222 | 2010 |
| Angiotensin–neprilysin inhibition versus enalapril in heart failure JJV McMurray, M Packer, AS Desai, J Gong, MP Lefkowitz, AR Rizkala, ... New England Journal of Medicine 371 (11), 993-1004, 2014 | 7499 | 2014 |
| 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines DC Goff Jr, DM Lloyd-Jones, G Bennett, S Coady, RB D’agostino, ... Circulation 129 (25_suppl_2), S49-S73, 2014 | 7453 | 2014 |
| Dapagliflozin in patients with heart failure and reduced ejection fraction JJV McMurray, SD Solomon, SE Inzucchi, L Køber, MN Kosiborod, ... New England Journal of Medicine 381 (21), 1995-2008, 2019 | 6672 | 2019 |
| Contribution of Working Group I to the fourth assessment report of the Intergovernmental Panel on Climate Change 2007 SD Solomon (No Title), 2007 | 6236* | 2007 |
| Recommendations for chamber quantification RM Lang, M Bierig, RB Devereux, FA Flachskampf, E Foster, PA Pellikka, ... European journal of echocardiography 7 (2), 79-108, 2006 | 4145 | 2006 |
| Cardiac-resynchronization therapy for the prevention of heart-failure events AJ Moss, WJ Hall, DS Cannom, H Klein, MW Brown, JP Daubert, ... New England Journal of Medicine 361 (14), 1329-1338, 2009 | 3686 | 2009 |
| Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both MA Pfeffer, JJV McMurray, EJ Velazquez, JL Rouleau, L Køber, ... New England Journal of Medicine 349 (20), 1893-1906, 2003 | 3414 | 2003 |
| Spironolactone for heart failure with preserved ejection fraction B Pitt, MA Pfeffer, SF Assmann, R Boineau, IS Anand, B Claggett, ... New England Journal of Medicine 370 (15), 1383-1392, 2014 | 2845 | 2014 |
| Renin–angiotensin–aldosterone system inhibitors in patients with Covid-19 M Vaduganathan, O Vardeny, T Michel, JJV McMurray, MA Pfeffer, ... New England Journal of Medicine 382 (17), 1653-1659, 2020 | 2735 | 2020 |
| Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis D Adams, A Gonzalez-Duarte, WD O’Riordan, CC Yang, M Ueda, ... New england journal of medicine 379 (1), 11-21, 2018 | 2728 | 2018 |
| Lixisenatide in patients with type 2 diabetes and acute coronary syndrome MA Pfeffer, B Claggett, R Diaz, K Dickstein, HC Gerstein, LV Køber, ... New England Journal of Medicine 373 (23), 2247-2257, 2015 | 2659 | 2015 |
| Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention SD Solomon, JJV McMurray, MA Pfeffer, J Wittes, R Fowler, P Finn, ... New England Journal of Medicine 352 (11), 1071-1080, 2005 | 2621 | 2005 |
| Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction NS Anavekar, JJV McMurray, EJ Velazquez, SD Solomon, L Kober, ... New England Journal of Medicine 351 (13), 1285-1295, 2004 | 2557 | 2004 |
| A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease MA Pfeffer, EA Burdmann, CY Chen, ME Cooper, D De Zeeuw, ... New England Journal of Medicine 361 (21), 2019-2032, 2009 | 2505 | 2009 |
| Potential effects of coronaviruses on the cardiovascular system: a review M Madjid, P Safavi-Naeini, SD Solomon, O Vardeny JAMA cardiology 5 (7), 831-840, 2020 | 2394 | 2020 |
| Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ... The Lancet 368 (9541), 1096-1105, 2006 | 2283 | 2006 |
John McMurrayUniversity of Glasgow.glasgow.ac.uk의 이메일 확인됨
